Scott Schwartz
Optometrist · Clinton, MINPI 1730491986
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Alcon at 52.2% of the total. Reporting peaked in 2020 at $1,345 and has fallen 68.9% since, to $418 in 2025. Among optometrist clinicians in MI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 97 payments — averaging $39.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$2K
- Johnson & Johnson Vision Care, Inc.$721
- Bausch & Lomb, A Division Of Bausch Health US, LLC$193
- Coopervision Inc.$187
- Kala Pharmaceuticals, Inc.$149
- Bausch & Lomb Americas Inc.$129
- plus $444 from 9 others
Across 302 payments — averaging $770.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Alcon Research LLC$214K
- Bausch Health US, LLC$18K
What the payments were for
- Consulting fees$2938%
- Speaking & faculty fees$50013%
- Travel & lodging$92524%
- Food & beverage$2,09255%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $1,987 |
| Johnson & Johnson Vision Care, Inc. | 21 | $721 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 3 | $193 |
| Coopervision Inc. | 12 | $187 |
| Kala Pharmaceuticals, Inc. | 7 | $149 |
| Bausch & Lomb Americas Inc. | 6 | $129 |
| Sun Pharmaceutical Industries Inc. | 7 | $125 |
| Shire North American Group Inc | 3 | $98 |
| Tarsus Pharmaceuticals, Inc. | 4 | $88 |
| Novartis | 3 | $59 |
| AbbVie | 1 | $22 |
| LKC Technologies, Inc. | 1 | $19 |
| Lombart Brothers, Inc. | 1 | $15 |
| Oyster Point Pharma, Inc. | 1 | $12 |
| ABB Con-cise Optical Group LLC | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DAILIES$538
- AIR OPTIX$500
- AIR OPTIX for Astigmatism$500
- Dailies Aqua Comfort Plus$500
- DAILIES TOTAL1$500
- Precision 1$500
- Acuvue$418
- ALDEN SCLERAL ZENLENS$125
How this compares
$3,810 in reported general payments places this provider in the 90th percentile of 1,523 optometrist providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 20 | $21,435 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 13 | $2,250 |
| Latanoprost | 78 | $1,062 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $22 | $21,43520 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,523 optometrist providers in Michigan.
Other optometrist in Clinton
- Jamie KuzniarBloomfield$473K
- Monica JohnsonbaughGrosse Pointe$393K
- Nicholas BrunsFlint$238K
- Jay CrankGrand Rapids$209K
- Jeffrey VaranelliWarren$204K
- Thomas RothAnn Arbor$98K
- Frances Poma NowinskiBloomfield Twp$91K
- Michael LipsonWalled Lake$77K
- Stephanie RamdassBig Rapids$59K
- Robert FarrellMount Clemens$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.